Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. [electronic resource]
Producer: 20070425Description: 332-41 p. digitalISSN:- 1592-8721
- Acute Disease
- Adult
- Aged
- Aged, 80 and over
- Boronic Acids -- pharmacology
- Bortezomib
- Cell Division -- drug effects
- Cell Line, Tumor -- drug effects
- Chemokines -- metabolism
- Chemotaxis -- drug effects
- DNA Replication -- drug effects
- Female
- Hematopoietic Cell Growth Factors -- pharmacology
- Humans
- Leukemia, Myeloid -- classification
- Male
- Middle Aged
- NF-kappa B -- biosynthesis
- Neoplasm Proteins -- biosynthesis
- Pyrazines -- pharmacology
- Receptors, Chemokine -- biosynthesis
- Recombinant Fusion Proteins -- pharmacology
- T-Lymphocytes -- drug effects
- Tumor Stem Cell Assay
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.